Young T. Hong

University of Cambridge — United Kingdom

Medicine · Health Sciences

42h-index6.6kcitations151works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(66), Dementia and Cognitive Impairment Research(44), Neuroinflammation and Neurodegeneration Mechanisms(35), Parkinson's Disease Mechanisms and Treatments(27), Functional Brain Connectivity Studies(18)

Publications151 total

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
The Lancet Neurology·2025· 1 citedOpen Access
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseases
2025Open Access
A pipeline for comparing and combining TSPO‐PET tracers in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease
Movement Disorders·2025Open Access
Comparing and combining TSPO-PET tracers in tauopathies
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
2025Open Access
Comparing and combining TSPO-PET tracers in tauopathies
2025Open Access
Peripheral-central immune crosstalk in Parkinson’s disease and its association with clinical severity
Brain Behavior and Immunity·2025· 4 citedOpen Access
Hippocampal perineuronal net degradation identifies prefrontal and striatal circuits involved in schizophrenia-like changes in marmosets
Science Advances·2025· 1 citedOpen Access
Post-mortem validation of <i>in vivo</i> TSPO PET as a microglial biomarker
Brain·2025· 18 citedOpen Access
Polygenic risk discriminates Lewy body dementia from Alzheimer's disease
Alzheimer s & Dementia·2025· 1 citedOpen Access
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
Brain Communications·2025Open Access
From glia to cytokine signatures across the Alzheimer’s spectrum
Alzheimer s & Dementia·2024Open Access
From glia to cytokine signatures across the Alzheimer's spectrum
Alzheimer s & Dementia·2024Open Access
Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration
Brain·2024· 31 citedOpen Access
Outcomes and Mechanisms Associated With Selective Thalamic Neuronal Loss in Chronic Traumatic Brain Injury
JAMA Network Open·2024· 6 citedOpen Access
<i>Post-Mortem</i> validation of <i>in vivo</i> 18kDa Translocator Protein (TSPO) PET as a microglial biomarker
2024Open Access
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome
Movement Disorders·2024· 3 citedOpen Access
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial
Alzheimer s & Dementia·2024· 20 citedOpen Access
Are central and systemic inflammation associated with fatigue in cerebral small vessel disease?
International Journal of Stroke·2024· 7 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Tim D. Fryer(47), Franklin I. Aigbirhio(41), John T. O’Brien(20), James B. Rowe(19), Luca Passamonti(17), P. Simon Jones(13), Jonathan Coles(13), W Richard Bevan‐Jones(11), Elijah Mak(11), Maura Malpetti(11), Jean‐Claude Baron(10), David Menon(10), Timothy Rittman(10), Guy Williams(8), Thomas Cope(8), Robert Arnold(8), Stephen J. Sawiak(8), Peter J. Nestor(7), Patricia Vázquez Rodríguez(7), David J. Williamson(7)